Anika Therapeutics Reports 1Q19 Orthobiologic Revenue of $21.7MM, +11.6% vs. 1Q18

By Mike Evers

Anika Therapeutics posts 1Q19 orthobiologic revenue of USD $21.7MM, +11.6% vs. 1Q18.

Member-Only Content

SUBSCRIBE Login

Product Labels: Viscosupplement

Tags: Revenue Report